Washington Trust’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
HF
TRCT
HIS
HJMC
TCM
EWA
Washington Trust's LABU Position: Q3 2020 in Review
Washington Trust sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2020, closing a stake of 6 shares — an estimated $7K sold.
Washington Trust first reported a position in LABU in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 20 funds tracked by Wall St. Rank hold LABU as of Q3 2020.
- Washington Trust reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2020 after selling out during the quarter.
- Washington Trust sold 6 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2020, an estimated $7K.
- Washington Trust first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and held it in 1 quarter.
- Washington Trust's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $7K in Q2 2020.
- 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2020.
Based on Washington Trust's 13F filing for Q3 2020, filed 5 Nov 2020.